Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) EBT Margin (2020 - 2025)

Historic EBT Margin for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to 32.32%.

  • RxSight's EBT Margin fell 144100.0% to 32.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 25.1%, marking a year-over-year decrease of 11900.0%. This contributed to the annual value of 19.59% for FY2024, which is 349600.0% up from last year.
  • As of Q3 2025, RxSight's EBT Margin stood at 32.32%, which was down 144100.0% from 34.94% recorded in Q2 2025.
  • In the past 5 years, RxSight's EBT Margin ranged from a high of 14.74% in Q4 2024 and a low of 275.15% during Q2 2021
  • Its 5-year average for EBT Margin is 97.37%, with a median of 66.21% in 2023.
  • The largest annual percentage gain for RxSight's EBT Margin in the last 5 years was 1994300bps (2021), contrasted with its biggest fall of -9546400bps (2021).
  • RxSight's EBT Margin (Quarter) stood at 186.87% in 2021, then surged by 48bps to 97.02% in 2022, then surged by 67bps to 32.18% in 2023, then skyrocketed by 54bps to 14.74% in 2024, then crashed by -119bps to 32.32% in 2025.
  • Its EBT Margin was 32.32% in Q3 2025, compared to 34.94% in Q2 2025 and 21.56% in Q1 2025.